Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

47.4%

9 terminated/withdrawn out of 19 trials

Success Rate

30.8%

-55.7% vs industry average

Late-Stage Pipeline

68%

13 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

8 withdrawn

Enrollment Performance

Analytics

Phase 3
9(47.4%)
Phase 4
4(21.1%)
Phase 2
3(15.8%)
Phase 1
2(10.5%)
Early Phase 1
1(5.3%)
19Total
Phase 3(9)
Phase 4(4)
Phase 2(3)
Phase 1(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT07375498Phase 1Not Yet Recruiting

Safety and Pharmacokinetics of Rescue Liposome in Healthy Adults

Role: lead

NCT05739734Early Phase 1Not Yet Recruiting

Safety of CRIS100 on Treatment Spinal Cord Injury

Role: lead

NCT03743103Phase 4Terminated

Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study (ETHICHS)

Role: lead

NCT03883763Phase 3Unknown

Hyperbaric Novabupi® in Spinal Anesthesia in Lower Limbs Vascular Surgery

Role: lead

NCT03324035Phase 3Unknown

Treatment of Neuropathic Pain in Leprosy

Role: collaborator

NCT02604186Phase 2Completed

Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia

Role: collaborator

NCT03242239Phase 1Completed

A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects

Role: collaborator

NCT01994967Phase 3Withdrawn

Phase III, Evaluate Noninferiority Between Levobupivacaine and Bupivacaine in Spinal Anesthesia.

Role: lead

NCT01308528Phase 3Completed

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

Role: lead

NCT02099695Phase 3Withdrawn

Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis

Role: lead

NCT00959400Phase 3Withdrawn

Efficacy and Safety Study of Fentanyl Transdermal (Fentanest®)

Role: lead

NCT02004626Phase 3Withdrawn

Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.

Role: lead

NCT00817830Phase 4Withdrawn

Cardiovascular Safety Study of Lodenafil Carbonate in Patients With Coronaropathy During Physical Effort

Role: lead

NCT01308047Phase 3Withdrawn

Comparing Heavy Levobupivacaine With Enantiomeric Excess of 50% and Heavy Racemic Bupivacaine.

Role: lead

NCT01303107Phase 3Withdrawn

Comparative Mixture of Non-racemic and Racemic Enantiomers of Bupivacaine in Cesarean

Role: lead

NCT01326078Phase 2Withdrawn

Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures.

Role: lead

NCT00932542Phase 2Unknown

Eutectic Mixture for Hemorrhoidectomy Postoperative

Role: collaborator

NCT01180283Phase 4Completed

Efficacy and Safety of Lodenafil Carbonate in the Treatment of Erectile Dysfunction in Patients With Diabetes.

Role: lead

NCT00523289Phase 4Unknown

Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus Block

Role: collaborator

All 19 trials loaded